Chugai Pharmaceutical Co. Balance Sheet

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2003
Cash & Equivalents	458,674	222,169	267,753	212,333	203,941	146,860	139,074	95,368	101,707	114,037	Upgrade
Short-Term Investments	280,308	280,938	204,217	166,287	129,117	102,533	104,018	110,176	134,419	116,030	Upgrade
Cash & Cash Equivalents	738,982	503,107	471,970	378,620	333,058	249,393	243,092	205,544	236,126	230,067	Upgrade
Cash Growth	46.88%	6.60%	24.66%	13.68%	33.55%	2.59%	18.27%	-12.95%	2.63%	-1.95%	Upgrade
Receivables	320,348	514,283	356,009	253,354	181,641	179,559	175,001	167,483	158,717	159,887	Upgrade
Inventory	273,480	292,206	208,838	183,893	168,122	159,360	169,056	185,440	161,135	139,571	Upgrade
Other Current Assets	33,616	26,941	26,844	19,039	16,859	11,781	11,992	20,293	11,795	9,379	Upgrade
Total Current Assets	1,366,426	1,336,537	1,063,661	834,906	699,680	600,093	599,141	578,760	567,773	538,904	Upgrade
Property, Plant & Equipment	420,701	386,651	352,107	297,490	265,308	222,388	171,569	157,081	153,545	140,245	Upgrade
Long-Term Investments	1,254	-279,101	-201,824	-163,446	-126,159	-92,810	-92,668	-100,470	-120,704	-105,275	Upgrade
Intangible Assets	19,860	25,141	21,974	23,880	23,540	22,699	21,078	19,299	13,511	11,286	Upgrade
Other Long-Term Assets	124,306	400,530	302,776	242,668	196,546	167,178	153,354	151,615	173,276	154,379	Upgrade
Total Long-Term Assets	566,121	533,221	475,033	400,592	359,235	319,455	253,333	227,525	219,628	200,635	Upgrade
Total Assets	1,932,547	1,869,758	1,538,694	1,235,498	1,058,915	919,548	852,473	806,285	787,401	739,538	Upgrade
Accounts Payable	54,234	209,835	152,266	100,396	77,635	71,706	63,518	72,346	78,353	62,694	Upgrade
Deferred Revenue	31	79	86	80	252	19,567	18,620	10,609	13,313	17,606	Upgrade
Current Debt	6,975	6,434	6,550	6,649	7,263	133	129	135	131	29	Upgrade
Other Current Liabilities	226,977	207,382	168,520	128,945	94,118	43,812	40,635	40,570	41,261	34,021	Upgrade
Total Current Liabilities	288,217	423,730	327,422	236,070	179,268	135,218	122,902	123,660	133,058	114,350	Upgrade
Long-Term Debt	6,480	-430	-490	-564	-643	82	207	510	604	185	Upgrade
Other Long-Term Liabilities	12,269	22,071	23,745	19,989	26,305	27,720	36,467	35,618	26,468	27,247	Upgrade
Total Long-Term Liabilities	18,749	21,641	23,255	19,425	25,662	27,802	36,674	36,128	27,072	27,432	Upgrade
Total Liabilities	306,966	445,371	350,677	255,495	204,930	163,020	159,576	159,788	160,130	141,782	Upgrade
Total Debt	13,455	14,109	16,040	11,284	12,752	215	336	645	735	214	Upgrade
Debt Growth	-4.64%	-12.04%	42.15%	-11.51%	5831.16%	-36.01%	-47.91%	-12.24%	243.46%	-8.15%	Upgrade
Common Stock	73,202	73,202	73,202	73,202	73,016	0	72,970	72,967	72,967	72,967	Upgrade
Retained Earnings	1,488,738	1,293,352	1,054,050	849,093	722,076	0	550,974	507,399	488,954	451,220	Upgrade
Comprehensive Income	-5,714	-10,972	-7,457	-9,878	-8,143	0	0	0	0	0	Upgrade
Shareholders' Equity	1,625,580	1,424,387	1,188,017	980,003	853,985	755,864	691,924	645,508	625,857	596,099	Upgrade
Total Liabilities and Equity	1,932,546	1,869,758	1,538,694	1,235,498	1,058,915	919,548	852,473	806,285	787,401	739,538	Upgrade
Net Cash / Debt	725,527	488,998	455,930	367,336	320,306	249,178	242,756	204,899	235,391	229,853	Upgrade
Net Cash / Debt Growth	48.37%	7.25%	24.12%	14.68%	28.55%	2.65%	18.48%	-12.95%	2.41%	-1.94%	Upgrade
Net Cash Per Share	440.92	297.20	277.12	223.29	194.77	75.76	73.91	62.43	71.75	70.17	Upgrade
Working Capital	1,078,209	912,807	736,239	598,836	520,412	464,875	476,239	455,100	434,715	424,554	Upgrade
Book Value Per Share	988.07	866.00	722.57	596.31	520.04	229.81	211.00	196.98	191.12	182.27	Upgrade

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.